SeaStar Medical Reports Pricing Of $9M Direct Offering Priced At-The-Market
Author: Benzinga Newsdesk | January 26, 2024 09:07am
The company has entered into a securities purchase agreement with a single institutional investor to purchase 10,840,761 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering. In a concurrent private placement, the Company also agreed to issue and sell to the investor Series A warrants to purchase up to an aggregate 10,840,761 shares of common stock, and Series B warrants to purchase up to an aggregate 5,420,381 shares of common stock.
Posted In: ICU